Compounds > azacitidine

azacitidine and Uveal Neoplasms

azacitidine has been researched along with Uveal Neoplasms in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Asnaghi, L; Eberhart, CG; Enke, R; Handa, JT; Merbs, SL; Rajaii, F1
Biondo, C; Catalano, T; Lentini, M; Teti, D; Venza, I; Venza, M; Visalli, M1
Beninati, C; Catalano, T; Teti, D; Venza, I; Venza, M; Visalli, M1
Frants, RR; Gruis, NA; Hurks, MHMH; Jager, MJ; Krijgsman, E; Ksander, BR; Pavey, S; Tensen, CP; van der Velden, PA; Willemze, R; Zuidervaart, W1
Jager, M; Ono, SJ; Radosevich, M1
Gollob, JA; Sciambi, CJ1
Bergman, W; Frants, RR; Gruis, NA; Hurks, H; Jager, MJ; Metzelaar-Blok, JA; Monique, H; van der Velden, PA1

Other Studies

7 other study(ies) available for azacitidine and Uveal Neoplasms

ArticleYear
The demethylating agent 5-Aza reduces the growth, invasiveness, and clonogenicity of uveal and cutaneous melanoma.
    Investigative ophthalmology & visual science, 2014, Aug-21, Volume: 55, Issue:10

    Topics: Animals; Antimetabolites, Antineoplastic; Azacitidine; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colony-Forming Units Assay; Decitabine; DNA Modification Methylases; DNA, Neoplasm; Humans; Melanoma; Melanoma, Cutaneous Malignant; Mice; Neoplasms, Experimental; Skin Neoplasms; Uveal Neoplasms

2014
Epigenetic regulation of p14ARF and p16INK4A expression in cutaneous and uveal melanoma.
    Biochimica et biophysica acta, 2015, Volume: 1849, Issue:3

    Topics: Adult; Azacitidine; Cell Line, Tumor; Cyclin-Dependent Kinase Inhibitor p16; Decitabine; DNA Methylation; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Histone Deacetylases; Humans; Melanoma; Promoter Regions, Genetic; Tumor Suppressor Protein p14ARF; Uveal Neoplasms

2015
DSS1 promoter hypomethylation and overexpression predict poor prognosis in melanoma and squamous cell carcinoma patients.
    Human pathology, 2017, Volume: 60

    Topics: Azacitidine; Biomarkers, Tumor; Carcinoma, Squamous Cell; Cell Line, Tumor; Decitabine; Disease-Free Survival; DNA Methylation; DNA Modification Methylases; Enzyme Inhibitors; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Kaplan-Meier Estimate; Male; Melanoma; Promoter Regions, Genetic; Proteasome Endopeptidase Complex; Skin Neoplasms; Time Factors; Treatment Outcome; Up-Regulation; Uveal Neoplasms

2017
Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development.
    International journal of cancer, 2003, Sep-10, Volume: 106, Issue:4

    Topics: Azacitidine; Biomarkers, Tumor; Decitabine; Disease Progression; DNA Methylation; DNA Modification Methylases; DNA Probes; Down-Regulation; Enzyme Inhibitors; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Liver Neoplasms; Melanoma; Neoplasm Proteins; Oligonucleotide Array Sequence Analysis; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; RNA, Neoplasm; Tissue Inhibitor of Metalloproteinase-3; Tissue Inhibitor of Metalloproteinases; Tumor Cells, Cultured; Uveal Neoplasms

2003
Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
    Experimental and molecular pathology, 2007, Volume: 82, Issue:1

    Topics: Azacitidine; Base Sequence; Blotting, Southern; Cell Line, Tumor; DNA Methylation; Eye; Gene Expression; Gene Expression Profiling; Gene Expression Regulation; Genes, MHC Class II; HeLa Cells; Humans; Interferon-gamma; Melanoma; Molecular Sequence Data; Nuclear Proteins; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Trans-Activators; Uveal Neoplasms

2007
Decitabine up-regulates S100A2 expression and synergizes with IFN-gamma to kill uveal melanoma cells.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Sep-01, Volume: 13, Issue:17

    Topics: Antimetabolites, Antineoplastic; Apoptosis; Azacitidine; Chemotactic Factors; Decitabine; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Interferon-alpha; Interferon-gamma; Melanoma; S100 Proteins; Tumor Cells, Cultured; Uveal Neoplasms

2007
Promoter hypermethylation: a common cause of reduced p16(INK4a) expression in uveal melanoma.
    Cancer research, 2001, Jul-01, Volume: 61, Issue:13

    Topics: Adult; Aged; Aged, 80 and over; Azacitidine; CpG Islands; Cyclin-Dependent Kinase Inhibitor p16; Decitabine; DNA Methylation; DNA, Neoplasm; Female; Gene Expression Regulation, Neoplastic; Gene Silencing; Humans; Male; Melanoma; Middle Aged; Promoter Regions, Genetic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured; Uveal Neoplasms

2001